ReviewJournal of clinical medicine2021

Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting.

Maria Corina Plaz Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.